Outlook 09/14: U.S. stock futures are shooting for a comeback after the tech-heavy Nasdaq ended its worst week since March. A series of deals are boosting sentiment: Gilead reached a $21B agreement to acquire Immunomedics, Nvidia is paying $40B to buy Arm Holdings from Japan's SoftBank and Oracle may be taking over TikTok's U.S. operations. On the coronavirus front, Pfizer said its coronavirus vaccine could be distributed to Americans before the end of the year, while AstraZeneca restarted Phase 3 trials in the U.K.
/ESZ20 Value: YVAH 3354 YPOC 3335 YVAL 3325 GAP 3324.25
/ES Plan: Last session market closed balanced, but overnight looks more bullish (PBT 3388), moving above Friday's value, so these are the initial balance options for today's opening:
A) If market remains above LIS YVAH 3354 with bullish internals, buy towards ONH 3375 and HVEs 3383-3398.
B) If market moves below LIS YVAH 3354 with bearish internals, sell towards ONL 3336.25 and GAP 3324.25
Note: Rollover. Pace of the Roll 60%. I'm quoting ESZ20 contract. Usually rollover days show divergences between Stocks vs. Futures, so setups that usually work well, may fail completely. Be selective and avoid overtrading, try conservative mode only.
Market Movers
11:30 3-Month Bill Auction
11:30 6-Month Bill Auction
Questions via @verniman direct message (RTH) or email (After Close).
Follow alerts using TweetDeck. Primary twitter language is English.
No unauthorized reproduction of this service without permission.
